Quantcast
Last updated on April 20, 2014 at 5:20 EDT

RxSaver™ Provides 544% ROI for Pharmaceutical Brands by Solving Prescription Abandonment

August 19, 2013

TrialCard announces the results of the RxSaver pilot, measuring the results for stopping prescription abandonment.

Cary, North Carolina (PRWEB) August 19, 2013

TrialCard announces the results of the RxSaver pilot, measuring the results for stopping prescription abandonment.

RxSaver was piloted with 10 of the top 35 brands by 2012 retail volume at nearly 500 pharmacies since March 1, 2013. Pharmacists in the RxSaver network have the opportunity to offer a copayment assistance program to a patient who was at risk for abandoning a prescription due to the out of pocket cost.

Based upon baseline data from the pilot pharmacies, 35% of patients who had out of pocket expenses higher than $45 were determined to be “at risk” for prescription abandonment. RxSaver rescued 1 in 5 of “at risk” prescriptions. The revenue gained from the rescued prescriptions represents a 544.5% ROI for the brands.

With a 544% ROI, RxSaver sparks organic growth for brands, by rescuing the prescriptions that prescribers have already written. RxSaver is the only prescription abandonment solution directly delivered from a pharmacist, the most trusted healthcare provider. RxSaver provides analytics that prove the rate of abandonment solution and ROI.

“Pharmaceutical brands, pharmacists, and patients all benefit from patients taking their prescriptions as written by their prescriber.” said David Cunningham, CEO, TrialCard. “RxSaver is a true solution for prescription abandonment that provides value to brands, pharmacists, and patients.”

About TrialCard Incorporated –

TrialCard Incorporated provides a comprehensive portfolio of Patient Access Solutions™ at Point of Care, Patient Access Management, and Point of Sale for the life-cycle of pharmaceutical brands. Since opening its doors in 2001, TrialCard has been awarded multiple patents related to the processing and marketing of patient access programs. TrialCard is the largest provider of patient access programs in the industry, processing over $1 billion in patient benefits per year to help brand manufactures achieve their goals with prescribers, patients, and pharmacists. For more information on TrialCard, please visit http://www.TrialCard.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11022507.htm


Source: prweb